Core Scientific (CORZR) Cash & Current Investments (2021 - 2026)

Core Scientific's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 52.49% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 52.49% YoY), while the FY2025 annual figure was $311.4 million, down 62.8% from the prior year.
• Cash & Current Investments came in at $1.1 billion for Q1 2026 at Core Scientific, up from $311.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $1.1 billion in Q1 2026 to a low of $37.6 million in Q3 2022.
• A 5-year average of $311.6 million and a median of $140.4 million in 2022 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments surged 18181.06% in 2022 and slumped 81.55% in 2023, its largest moves.
• Core Scientific's Cash & Current Investments stood at $52.2 million in 2022, then jumped by 33.44% to $69.7 million in 2023, then soared by 1100.68% to $837.0 million in 2024, then sank by 62.8% to $311.4 million in 2025, then jumped by 242.15% to $1.1 billion in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $1.1 billion, $311.4 million, and $453.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison